Order SELL UTHR NASDAQ.NMS Stop 209.45 LMT 209.45 will be automatically canceled at 20230401 01:00:00 EST
UTHR daily bearish hammer in selling resistance zone
Order SELL UTHR NASDAQ.NMS Stop 211.77 LMT 211.77 will be automatically canceled at 20230401 01:00:00 EST
UTHR daily indecision hammer at resistance can be nice ride into support zone.
Could break either way. Any triangle can break up or down. It is a consolidation pattern
Also a H&S pattern.
The talking heads are saying Buy healthcare so be safe, or not. The players will run HC up until it will cave as well.
They usually do the same thing over and over and suck us in a long the way.
No recommendation/Just some stocks do not live where...
UTHR has no resistance (shown with dotted green horizontal)
A breakout should ensue and lead to further bullish increases
This is all occurring along a strong up trend line formed by the bulls
I went long UTHR on Tuesday, as per the position marked.
Its consolidating nicely after breaking out from a previous high and looked really good.
Unfortunately I messed the whole thing up!!!
I got a pretty nasty entry (got a little too trigger happy on the breakout).
My strategy as always but especially so in this market is too keep losses small (typically 5 -...
$UTHR has built a text book classic Head & Shoulders top. It is resting near its neckline breakdown area $213.75. Consolidation above the neckline breakdown area of $215-$220 has created a bearish looking pennant formation. All in all $UTHR looks sickly, and probably headed for lower prices. If neckline of $213.75 breaks, downside obj =$190.00
Price is on the neckline.
Earnings miss.
Entry short with a break of the neckline and a downtrend.
No recommendation.
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and...
$UTHR In this bear market I am looking for a failure on the double top break-out. I know the RS line is strong and we have somewhat of a basing pattern, although wide and lose since April of 2021. Just thoughts. If history (of this stock) repeats you might want to consider a short if this fails near this double top. Low risk with stop just above ATH. I'll update...
$UTHR Breakout in 1h Chart on above average volume after consolidation phase - Target 250$
All Entry Criteria have been met:
1. Price above 10, 20 & 50 EMA --> Check
2. Consolidation Phase in Uptrend --> Check
3. Breakout on above average Volume --> Check
United Therapeutics spent more than a year consolidating around its 2015 highs. Now the biotech may be attempting a breakout.
Notice the surge to new all-time highs late last month. The rally followed news that the Food & Drug Administration approved its Tyvaso DPI hypertension drug for two applications. (There were worries of a narrower approval.)
UTHR paused...
More things down the pipeline to come, and this company is making tons of money. This price is going to fill the gap for sure and stay above 200 in Q2.
